| It is not yet the time to stop screening diabetic patients for silent myocardial ischaemia. | |
| | |
MedLine Citation:
|
PMID: 20189425 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Despite the intensified control of risk factors, silent myocardial ischaemia (SMI) is still a frequent complication of diabetes that is also associated with a higher risk of cardiac events. The objectives of this review are to summarize the importance of screening for SMI in a subset of asymptomatic diabetic patients. There is evidence that screening markedly improves the evaluation of cardiovascular risk compared with the usual risk scores. New markers, validated by large-scale studies, are needed to help in identifying the patients with silent coronary stenoses, thereby lowering the number of screened patients. Some indications of benefit with revascularization in patients with silent coronary stenoses are also available. Although it is not yet time to stop screening diabetic patients for SMI, such screening should focus on patients who are at high or intermediate cardiovascular risk. Guidelines need to be updated to increase the value of screening. |
| | |
Authors:
|
P Valensi; E Cosson |
Related Documents
:
|
23135865 - New strategy for the treatment of type 2 diabetes mellitus with incretin-based therapy. 23592065 - No association between perception of family functioning and treatment modality for chro... 23385835 - Gout, diabetes and cardiovascular disease in the aotearoa new zealand adult population:... 16193255 - Chorea induced by non-ketotic hyperglycaemia: a case report. 19252135 - Genetic variation in kcnq1 associates with fasting glucose and beta-cell function: a st... 1875725 - Effects of age on diabetes- and insulin-induced changes in pancreatic levels of alpha-a... |
Publication Detail:
|
Type: Journal Article; Review Date: 2010-02-26 |
Journal Detail:
|
Title: Diabetes & metabolism Volume: 36 ISSN: 1878-1780 ISO Abbreviation: Diabetes Metab. Publication Date: 2010 Apr |
Date Detail:
|
Created Date: 2010-04-26 Completed Date: 2010-08-02 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9607599 Medline TA: Diabetes Metab Country: France |
Other Details:
|
Languages: eng Pagination: 91-6 Citation Subset: IM |
Copyright Information:
|
(c) 2010 Elsevier Masson SAS. All rights reserved. |
Affiliation:
|
Department of Endocrinology-Diabetology-Nutrition, Paris-Nord University, Jean Verdier Hospital, AP-HP, avenue du 14-juillet, 93143 Bondy cedex, France. paul.valensi@jvr.aphp.fr |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Diabetes Mellitus, Type 2
/
complications* Female Humans Male Myocardial Ischemia / diagnosis*, prevention & control Prognosis Risk Factors |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: To establish nurse research priorities in Spain: Delphi study.
Next Document: Teeth and irradiation: Dental care and treatment of osteoradionecrosis after irradiation in head and...